RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models (Q38733964)
Jump to navigation
Jump to search
scientific article published on 31 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models |
scientific article published on 31 August 2016 |
Statements
1 reference
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models (English)
1 reference
Pavel Strop
1 reference
Thomas-Toan Tran
1 reference
Magdalena Dorywalska
1 reference
Kathy Delaria
1 reference
Russell Dushin
1 reference
Oi Kwan Wong
1 reference
Wei-Hsien Ho
1 reference
Dahui Zhou
1 reference
Aidong Wu
1 reference
Eugenia Kraynov
1 reference
Laura Aschenbrenner
1 reference
Bora Han
1 reference
Christopher J O'Donnell
1 reference
Jaume Pons
1 reference
Arvind Rajpal
1 reference
Dave L Shelton
1 reference
Shu-Hui Liu
1 reference
31 August 2016
1 reference
1 reference
Identifiers
1 reference